Malek Lukasz A, Reynolds Harmony R, Forman Sandra A, Vozzi Carlos, Mancini G B John, French John K, Dziarmaga Mieczyslaw, Renkin Jean P, Kochman Janusz, Lamas Gervasio A, Hochman Judith S
Institute of Cardiology, Warsaw, Poland.
Am Heart J. 2009 Apr;157(4):724-32. doi: 10.1016/j.ahj.2008.12.008.
We analyzed a prespecified hypothesis of the Occluded Artery Trial (OAT) that late percutaneous coronary intervention (PCI) of the infarct-related artery (IRA) would be most beneficial for patients with anterior myocardial infarction (MI).
Two thousand two hundred one stable, high-risk patients with total occlusion of the IRA (793 left anterior descending [LAD]) on days 3 to 28 (minimum of 24 hours) after MI were randomized to PCI and stenting with optimal medical therapy (1,101 patients) or to optimal medical therapy alone (1,100 patients). The primary end point was a composite of death, recurrent MI, or hospitalization for class IV heart failure.
The 5-year cumulative primary end point rate was more frequent in the LAD group (19.5%) than in the non-LAD group (16.4%) (HR 1.34, 99% CI 1.00-1.81, P = .01). Within the LAD group, the HR for the primary end point in the PCI group (22.7%) compared with the medical therapy group (16.4%) was 1.35 (99% CI 0.86-2.13, P = .09), whereas in the non-LAD group the HR for the primary end point in PCI (16.9%) compared with medical therapy (15.8%) was 1.03 (99% CI 0.70-1.52, P = .83) (interaction P = .24). The results were similar when the effect of PCI was assessed in patients with proximal LAD occlusion.
In stable patients, persistent total occlusion of the LAD post MI is associated with a worse prognosis compared with occlusion of the other IRAs. A strategy of PCI of occluded LAD IRA >24 hours post MI in stable patients is not beneficial and may increase risk of adverse events in comparison to optimal medical treatment alone.
我们分析了闭塞动脉试验(OAT)的一个预先设定的假设,即梗死相关动脉(IRA)的晚期经皮冠状动脉介入治疗(PCI)对前壁心肌梗死(MI)患者最为有益。
2201例在心肌梗死后3至28天(至少24小时)IRA完全闭塞的稳定高危患者(793例左前降支[LAD])被随机分为PCI加支架置入联合最佳药物治疗组(1101例患者)或单纯最佳药物治疗组(1100例患者)。主要终点是死亡、复发性心肌梗死或因IV级心力衰竭住院的复合终点。
LAD组5年累积主要终点发生率(19.5%)高于非LAD组(16.4%)(风险比1.34,99%可信区间1.00 - 1.81,P = 0.01)。在LAD组中,PCI组主要终点发生率(22.7%)与药物治疗组(16.4%)相比,风险比为1.35(99%可信区间0.86 - 2.13,P = 0.09),而在非LAD组中,PCI组主要终点发生率(16.9%)与药物治疗组(15.8%)相比,风险比为1.03(99%可信区间0.70 - 1.52,P = 0.83)(交互作用P = 0.24)。在评估近端LAD闭塞患者的PCI效果时,结果相似。
在稳定患者中,与其他IRA闭塞相比,心肌梗死后LAD持续完全闭塞与更差的预后相关。对于稳定患者,在心肌梗死后>24小时对闭塞的LAD IRA进行PCI的策略并无益处,与单纯最佳药物治疗相比,可能会增加不良事件风险。